From 2017 to 2023, the global nanomedicine market is expected to grow at a CAGR of 12.6 percent, from $111,912 million in 2016 to $261,063 million. Nanomedicine is one of the applications of nanotechnology that is employed in biological systems diagnosis, treatment, monitoring, and control. To improve pharmaceutical delivery, nanomedicine manipulates materials at the nanoscale. As a result, Nanomedicines Market has made it easier to cure a variety of ailments. Nanomedicine is still in its infancy, with a number of products in development. Around 230 nanomedicine compounds were identified in 2015, according to Nanobiotix (a nanomedicine business), and are either marked or in the trial phase. Furthermore, according to the firm, there are 49 nanomedicine products on the market, with another 122 in the clinical pipeline, either in Phase 1 or Phase 2.
Read More @ https://cmiinfonest.blogspot.com/2022/02/the-global-nanomedicine-market-is.html
